Sangamo Therapeutics Inc (NASDAQ:SGMO)
| 0.618 BATS BZX Real-Time Price As of 3:13pm ET |  +0.0188 / +3.14%Today’s Change | 0.56 Today|||52-Week Range 5.27 | -80.32% Year-to-Date |
Latest SGMO News | Press Releases
No recent news for Sangamo Therapeutics Inc.
Today’s Trading
| Previous close | 0.60 |
| Today’s open | 0.60 |
| Day’s range | 0.56 - 0.62 |
| Volume | 53,223 |
| Average volume (3 months) | 1,964,166 |
| Market cap | $137.3M |
Data as of 3:13pm ET, 09/28/2023
Growth & Valuation
| Earnings growth (last year) | -1.02% |
| Earnings growth (this year) | +29.36% |
| Earnings growth (next 5 years) | +27.82% |
| Revenue growth (last year) | +0.54% |
| P/E ratio | NM |
| Price/Sales | 4.35 |
| Price/Book | 0.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| KODKodiak Sciences Inc | -0.12 | -6.15% |
| CUECue Biopharma Inc | -0.08 | -3.09% |
| ---- | ||
| VXRTVaxart Inc | +0.03 | +3.45% |
Data as of 3:13pm ET, 09/28/2023
Financials
| Next reporting date | November 8, 2023 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $111.3M |
| Annual profit (last year) | -$192.3M |
| Net profit margin | -172.76% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Brisbane, California |
Forecasts
